After a 4-month investigation, Nature has decided to retract viral PD-1 study that tied lung cancer survival to treatment timing https://t.co/nnVSmWU1Pf
After leaving his mark on the company through a series of high-profile M&A deals, Pfizer’s CFO Dave Denton is staging an exit
https://t.co/KGPYfxTTyc
With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the “biopharma ecosystem is back to full health.” https://t.co/nqBtuWHdGr
Today on The Top Line, Fierce EIC @AylaEllison sits down with Ipsen's R&D chief to discuss the biopharma's approach to partnerships, its strategy for expanding the pipeline, and where its focus is in 2026. https://t.co/2TVNrouM2Q